Literature DB >> 3562827

Occult breast cancer: prevalence and radiographic detectability.

S R Pollei, F A Mettler, S A Bartow, G Moradian, M Moskowitz.   

Abstract

The radiographic detectability of occult breast cancer has been difficult to determine. A prospective study of breast disease was carried out that involved the performance of subcutaneous mastectomies in 519 consecutive cases of traumatic or initially unexplained death in New Mexico. Routine mammograms and radiographs of 1-cm specimens were obtained. At least 18 biopsies were performed in each subject. Carcinoma was identified in ten subjects; one subject had metastatic carcinoma from the lung, and two subjects had bilateral breast cancer, for a total of 11 breast cancers identified with microscopic examination. Two of the cancers were seen on whole-breast mammograms, and six were seen on radiographs of thin-section specimens. Four of the 11 breast cancers were apparent only on histologic study of breast tissue that was not suggestive of malignancy. No cancer was found in subjects under the age of 39 years. Five carcinomas were found in the 40-69-year age group; six were found in the 70-year and over age group. No correlation was noted between the radiographic Wolfe parenchymal patterns and the prevalence of breast cancer.

Entities:  

Mesh:

Year:  1987        PMID: 3562827     DOI: 10.1148/radiology.163.2.3562827

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

Review 1.  Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast.

Authors:  S A Bartow
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

2.  Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-04-01

Review 3.  Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy.

Authors:  Ute Kettritz
Journal:  Eur Radiol       Date:  2007-09-27       Impact factor: 5.315

Review 4.  The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.

Authors:  Lina Romero; Iraj Khalkhali; Hernan I Vargas
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 5.  The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk.

Authors:  Kathryn B Horwitz
Journal:  Mol Endocrinol       Date:  2008-10-09

6.  Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis.

Authors:  Kathryn B Horwitz; Carol A Sartorius
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

Review 7.  Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.

Authors:  I Khalkhali; I Mena; L Diggles
Journal:  Eur J Nucl Med       Date:  1994-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.